AI in clinical trials presents a data-driven model
Clinical trials are a significant part of the drug development cycle. However, the process has remained unchanged in recent ...
The inconvenient patients Australia’s COVID-19 response left behind
Australia's COVID-19 response saved countless lives, but it also left hundreds of people believing they were suffering a constellation of strange symptoms from the vaccines. Now they're fighting a ...
AstraZeneca Chair Buys Shares, Signals Confidence
AstraZeneca (GB:AZN) has released an update. Michel Demaré, the Non-Executive Chair of AstraZeneca, recently purchased 2,000 ordinary shares of ...
AstraZeneca CEO’s Share Purchase Signals Confidence
AstraZeneca (GB:AZN) has released an update. AstraZeneca’s CEO, Pascal Soriot, has made a substantial investment in the company by ...
Gene Editing Market to Hit USD 7.59 Billion by 2029 with 10.2% CAGR | MarketsandMarkets™
The global gene editing market is expected to reach USD 7.59 billion in 2029 from USD 4.66 billion in 2024, at a CAGR of 10.2 ...